Reviews of Amplifon hearing aids cover a wide spectrum, from complete satisfaction to marked disappointment. To assess the quality of the devices, the follow-up and value for money offered by this Italian brand present in over 29 countries, it is better to rely on recurring trends rather than isolated testimonials.
Amplifon Restructuring and Consequences for Audioprosthetist Follow-Up
Since 2025, Amplifon has been rolling out an internal program called “Fit4Growth” which has led to the closure of approximately 250 centers deemed underperforming across the group.
This restructuring explains some recent negative feedback. Users report a more limited availability of their usual center or transfers to other agencies, sometimes far from their home. For a hearing aid user, regular follow-up by an audioprosthetist who knows their file is crucial. A change of center during care can affect the quality of adjustment and listening.
A comparison of reviews on Amplifon hearing aids highlights this aspect of follow-up, often overlooked in favor of the technical characteristics of the prostheses themselves.
On the other hand, this rationalization of the network is accompanied by an improvement in the group’s operational margins, which could ultimately translate into better investment in the maintained centers.
Amplifon Reviews Compared to Competing Brands: Comparative Table
To place Amplifon in the landscape of audioprosthetists, here is a summary of the criteria that most often appear in user feedback.
| Criterion | Amplifon | Audika | Independent Audioprosthetists |
|---|---|---|---|
| Network of centers in France | Over 700 centers | Over 600 centers | Variable by region |
| Range of hearing aids | Proprietary ranges (Ampli-Mini, Ampli-Power) + third-party brands | Multiple brands (Phonak, Oticon, etc.) | Access to all brands on the market |
| Recurring strength in reviews | Welcoming center, initial hearing assessment | Diversity of brands offered | Impartial advice, no proprietary range |
| Recurring weakness in reviews | Orientation towards in-house ranges, uneven post-purchase follow-up | Sometimes long appointment wait times | Less dense network, no national number |
This table highlights a clear divide. Amplifon prioritizes its proprietary white-label ranges, manufactured by subcontractors. Independent audioprosthetists, on the other hand, have no in-house range to push and can guide the choice solely based on the patient’s hearing profile.
Ampli-Mini and Ampli-Power Ranges: What Users Say
Amplifon’s two flagship ranges, Ampli-Mini (discreet hearing aid) and Ampli-Power (extended battery life), concentrate most of the reviews. Positive feedback focuses on the compact design of the Ampli-Mini and its discretion in the ear. The Ampli-Power receives favorable comments from users suffering from severe hearing loss, who appreciate its power.
Critiques focus on another area. The pricing of in-house ranges remains opaque in Amplifon’s communication. Several users note that it is difficult to obtain a clear quote before the first appointment at the center. This lack of pricing transparency fuels a significant portion of negative reviews.
Another point that comes up regularly is the comparison with devices from brands like Phonak, Signia, or Oticon sold by other retailers. Users who have tested both report that devices from recognized brands offer finer adjustments and a wider ecosystem of accessories (remote microphones, advanced Bluetooth connectivity).
Factors Influencing Long-Term Satisfaction
Beyond the initial choice of device, three factors determine long-term satisfaction:
- The quality of successive adjustments by the audioprosthetist, which requires several listening sessions in real conditions during the first weeks
- The responsiveness of the after-sales service in case of malfunction or discomfort, a point on which Amplifon reviews are very polarized depending on the centers
- The ability to change devices or brands without starting from scratch, easier with an independent than in a proprietary network
Amplifon’s Commercial Growth and Discrepancy with User Reviews
In 2026, Amplifon reported its strongest organic growth in two years, with a notable increase in the second quarter and a first half above 3%. Adjusted net profit has significantly increased during the same period.
These financial performances coexist with contrasting user reviews. This discrepancy is partly explained by volume: Amplifon is gaining market share thanks to its dense network and hearing health campaigns (free hearing tests, call to 0800), which compensates for the departures of dissatisfied customers.
The global demand for hearing aids is growing by about 3% per year. Amplifon is outperforming this market, meaning that the brand is attracting new patients faster than it is losing them. Negative reviews, although visible online, do not hinder the overall purchasing dynamic.
Criteria for Choosing a Hearing Aid Beyond the Brand
The most useful reviews, regardless of the network, converge on one observation: the choice of audioprosthetist matters as much as the choice of device. A high-end device poorly adjusted will yield worse results than an entry-level model perfectly suited to the ear profile.
- Check that the center offers a minimum 30-day trial with the possibility of changing the model
- Request a written quote detailing the price of the device, coverage by health insurance and mutual insurance, and the cost of follow-up over several years
- Ensure that the audioprosthetist works with multiple brands and is not limited to a proprietary range
The 100% Health reform has made some hearing aids accessible with no out-of-pocket costs. At Amplifon as elsewhere, these models exist, but reviews indicate that advisors sometimes steer the discussion towards higher ranges. Asking the question right from the first appointment helps clarify the options available in each price range.
The hearing aid market remains a sector where the human relationship with the audioprosthetist weighs more than any score on a review platform. Amplifon’s financial data shows a brand in good commercial health, while field feedback highlights the quality gap from one center to another.
